These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12958113)

  • 21. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
    Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
    Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.
    Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD
    Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Hur C
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
    [No Abstract]   [Full Text] [Related]  

  • 25. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel.
    Corley DA
    J Natl Cancer Inst; 2011 Jul; 103(13):994-5. PubMed ID: 21680911
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
    Weston AP; Sharma P; Mathur S; Banerjee S; Jafri AK; Cherian R; McGregor D; Hassanein RS; Hall M
    Am J Gastroenterol; 2004 Sep; 99(9):1657-66. PubMed ID: 15330898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
    Achkar E; Carey W
    Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland.
    Murphy SJ; Dickey W; Hughes D; O'Connor FA
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1029-35. PubMed ID: 16148547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
    Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
    Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
    J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Barrett esophagus as precancerous lesion].
    Ferrando J; Reig G
    Rev Esp Enferm Dig; 1991 Aug; 80(2):83-6. PubMed ID: 1790085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus: does the incidence of adenocarcinoma matter?
    Cameron AJ
    Am J Gastroenterol; 1997 Feb; 92(2):193-4. PubMed ID: 9040189
    [No Abstract]   [Full Text] [Related]  

  • 40. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro.
    Wani S; Choi W; Sharma P
    Endoscopy; 2007 Jul; 39(7):643-6. PubMed ID: 17611920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.